Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line - PubMed (original) (raw)
Comparative Study
. 2003 Sep 18;22(40):6204-13.
doi: 10.1038/sj.onc.1206653.
Affiliations
- PMID: 13679859
- DOI: 10.1038/sj.onc.1206653
Comparative Study
Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line
Shaowen Wang et al. Oncogene. 2003.
Abstract
The dynamic balance between histone acetylation and deacetylation plays a significant role in the regulation of gene transcription. Much of our current understanding of this transcriptional control comes from the use of HDAC inhibitors such as trapoxin A (TPX), which leads to hyperacetylated histone, alters local chromatin architecture and transcription and results in tumor cell death. In this study, we treated tumor cells with TPX and HDAC1 antisense oligonucleotides, and analysed the transcriptional consequences of HDAC inhibition. Among other genes, the small GTPase RhoB was found to be significantly upregulated by TPX and repressed by HDAC1. The induction of RhoB by HDAC inhibition was mediated by an inverted CCAAT box in the RhoB promoter. Interestingly, measurement of RhoB transcription in approximately 130 tumor-derived cell lines revealed low expression in almost all of these samples, in contrast to RhoA and RhoC. Accumulating evidence indicates that the small GTPase Rho proteins are involved in a variety of important processes in cancer, including cell transformation, survival, invasion, metastasis and angiogenesis. This study for the first time demonstrates a link between HDAC inhibition and RhoB expression and provides an important insight into the mechanisms of HDAC-mediated transcriptional control and the potential therapeutic benefit of HDAC inhibition.
Similar articles
- Transcription regulation by histone deacetylases.
Wang S, Yan-Neale Y, Zeremski M, Cohen D. Wang S, et al. Novartis Found Symp. 2004;259:238-45; discussion 245-8, 285-8. Novartis Found Symp. 2004. PMID: 15171258 Review. - Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoter.
Delarue FL, Adnane J, Joshi B, Blaskovich MA, Wang DA, Hawker J, Bizouarn F, Ohkanda J, Zhu K, Hamilton AD, Chellappan S, Sebti SM. Delarue FL, et al. Oncogene. 2007 Feb 1;26(5):633-40. doi: 10.1038/sj.onc.1209819. Epub 2006 Aug 14. Oncogene. 2007. PMID: 16909123 - Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C. Tada Y, et al. J Natl Cancer Inst. 2006 Mar 15;98(6):396-406. doi: 10.1093/jnci/djj093. J Natl Cancer Inst. 2006. PMID: 16537832 - Histone deacetylase inhibitors: multifunctional anticancer agents.
Liu T, Kuljaca S, Tee A, Marshall GM. Liu T, et al. Cancer Treat Rev. 2006 May;32(3):157-65. doi: 10.1016/j.ctrv.2005.12.006. Epub 2006 Mar 3. Cancer Treat Rev. 2006. PMID: 16516391 Review.
Cited by
- Graphene-based nanomaterials for cancer therapy and anti-infections.
Wang Y, Li J, Li X, Shi J, Jiang Z, Zhang CY. Wang Y, et al. Bioact Mater. 2022 Feb 5;14:335-349. doi: 10.1016/j.bioactmat.2022.01.045. eCollection 2022 Aug. Bioact Mater. 2022. PMID: 35386816 Free PMC article. Review. - Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification.
Yeh SJ, Chang CA, Li CW, Wang LH, Chen BS. Yeh SJ, et al. Oncotarget. 2019 Jun 4;10(38):3760-3806. doi: 10.18632/oncotarget.26940. eCollection 2019 Jun 4. Oncotarget. 2019. PMID: 31217907 Free PMC article. - Regulation of RhoB Gene Expression during Tumorigenesis and Aging Process and Its Potential Applications in These Processes.
Gutierrez E, Cahatol I, Bailey CAR, Lafargue A, Zhang N, Song Y, Tian H, Zhang Y, Chan R, Gu K, Zhang ACC, Tang J, Liu C, Connis N, Dennis P, Zhang C. Gutierrez E, et al. Cancers (Basel). 2019 Jun 13;11(6):818. doi: 10.3390/cancers11060818. Cancers (Basel). 2019. PMID: 31200451 Free PMC article. Review. - Functionalized MoS2 Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy.
Yin F, Anderson T, Panwar N, Zhang K, Tjin SC, Ng BK, Yoon HS, Qu J, Yong KT. Yin F, et al. Nanotheranostics. 2018 Aug 25;2(4):371-386. doi: 10.7150/ntno.27308. eCollection 2018. Nanotheranostics. 2018. PMID: 30324083 Free PMC article. - Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.
Nomikou E, Livitsanou M, Stournaras C, Kardassis D. Nomikou E, et al. Cell Mol Life Sci. 2018 Jun;75(12):2111-2124. doi: 10.1007/s00018-018-2787-y. Epub 2018 Mar 2. Cell Mol Life Sci. 2018. PMID: 29500478 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous